Vedanta Biosciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Vedanta Biosciences sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Vedanta Biosciences: 5 sponsored US clinical trials, 1 recruiting.
Vedanta Biosciences sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diarrhea Infectious, with 1 trials.
Upper-quartile sponsor footprint
Vedanta Biosciences sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452
VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
NCT05370885
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
NCT04208958
Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT03788434
First-in-human Study of VE303 in Healthy Adult Volunteers
NCT04236778
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Therapeutic Areas
What is open in the Vedanta Biosciences pipeline
1 recruiting of 5 indexed (20% open); 3 completed (60%).
Phase mix: 1 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Diarrhea Infectious (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Vedanta Biosciences: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Vedanta Biosciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Vedanta Biosciences page
5 registered trials is a research-attention snapshot, not an endorsement of Vedanta Biosciences or any single study.
- 1 of Vedanta Biosciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Diarrhea Infectious is the condition Vedanta Biosciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diarrhea Infectious trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vedanta Biosciences pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.